Sea Crest Wealth Management, LLC Bio Rad Laboratories, Inc. Transaction History

Sea Crest Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$463.67 - $597.16 $24,574 - $31,649	53 New	53 $26,000
Q2 2019 Jul 19, 2019	SELL	$286.93 - $312.59 $10,329 - $11,253	-36 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$224.3 - $317.41 $1,121 - $1,587	5 Added 16.13%	36 $11,000
Q4 2018 Feb 13, 2019	SELL	$220.1 - $309.0 $220 - $309	-1 Reduced 3.13%	31 $7,000
Q2 2018 Aug 03, 2018	SELL	$244.1 - $303.88 $1,952 - $2,431	-8 Reduced 20.0%	32 $9,000
Q4 2017 Feb 02, 2018	BUY	$216.94 - $271.3 $8,677 - $10,852	40	40 $10,000

455

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.72B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.